Preventing stroke in people with atrial fibrillation: A cross-sectional study

Journal of Public Health

Volumn 27, Issue 1, 2005, Pages 85-92

  De Lusignan, Simon ^a   Van Vlymen, Jeremy ^a   Hague, Nigel ^a   Thana, Lavanya ^a   Chan, Tom ^b   Dzregah, Billy ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b SURREY AND BORDERS PARTNERSHIP NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Atrial fibrillation; Comparative study; Hypertension; Primary health care; Standards; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; WARFARIN;

ADULT; AGED; AGING; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; COMORBIDITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INFORMATION PROCESSING; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; STROKE; UNITED KINGDOM;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; CARDIOVASCULAR DISEASES; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; ENGLAND; FAMILY PRACTICE; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION; WALES; WARFARIN;

EID: 16344381155     PISSN: 17413842     EISSN: None     Source Type: Journal    
DOI: 10.1093/pubmed/fdh201     Document Type: Article

References (39)

1. Lip GYH, Beevers DG. ABC of atrial fibrillation: History, epidemiology and importance of atrial fibrillation. Br Med J 1995; 311: 1361-1363.
2. Stewart S, Murphy N, Walker A, McGuire A, McMurray JJ. Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK. Heart 2004; 90: 286-292.
3. Majeed A, Moser K, Carroll K. Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994-1998: analysis of data from the general practice research database. Heart 2001; 86: 284-288.
4. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998; 82: 2N-9N.
5. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 1995; 155: 469-473.
6. Carroll K, Majeed A. Comorbidity associated with atrial fibrillation: a general practice-based study. Br J Gen Pract 2001; 51: 884-6, 889-91.
7. O'Rourke F, Dean N, Akhtar N, Shuaib A. Current and future concepts in stroke prevention. CMAJ 2004; 170: 1123-1113.
8. Lawes CM, Bennett DA, Feigin VL, Rodgers A. Blood pressure and stroke: an overview of published reviews. Stroke 2004; 35: 1024.
9. Ryder KM, Benjamin EJ. Epidemiology and significance of atrial fibrillation. Am J Cardiol 1999; 84: 131R-138R.
10. Koudstaal P. Anticoagulants for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischaemic attack (Cochrane Review). The Cochrane Libary (Issue 4). Oxford: Update Software, 2000.
11. Amarenco P, Lavallee P, Touboul PJ. Stroke prevention, blood cholesterol, and statins. Lancet Neurol 2004; 3: 271-278.
12. Hajat C, Tilling K, Stewart JA, Lemic-Stojcevic N, Wolfe CD. Ethnic differences in risk factors for ischemic stroke: a European case-control study. Stroke 2004; 35: 1562-1567.
13. Diaz J, Sempere AP. Cerebral ischemia: new risk factors. Cerebrovasc Dis 2004; 17 [Suppl 1]: 43-50.
14. Leys D, Deplanque D, Mounier-Vehier C, Mackowiak-Cordoliani MA, Lucas C, Bordet R. Stroke prevention: management of modifiable vascular risk factors. J Neurol 2002; 249: 507-517.
15. McNamara RL, Tamariz LJ, Segal JB, Bass EB. Management of atrial fibrillation: review of the evidence for the role of pharmacologic therapy, electrical cardioversion, and echocardiography. Ann Intern Med 2003; 139: 1018-1033.
16. Deplanque D, Leys D, Parnetti L, Schmidt R, Ferro J, De Reuck J, Mas JL, Gallai V; SAFE II Investigators. Stroke prevention and atrial fibrillation: reasons leading to an inappropriate management. Main results of the SAFE II study. Br J Clin Pharmacol 2004; 57: 798-806.
17. Barnett HJ. Stroke prevention in the elderly. Clin Exp Hypertens 2002; 24: 563-571.
18. Freeman AC, Sweeney K. Why general practitioners do not implement evidence: qualitative study. Br Med J 2001; 323: 1100-1102.
19. Lipman T, Murtagh MJ, Thomson R. How research-conscious GPs make decisions about anticoagulation in patients with atrial fibrillation: a qualitative study. Fam Pract 2004; 21: 290-298.
20. National Statistics. Health Statistics Quarterly Summer 2004; 22: 37, Table 1.4. Population: age and sex. Available at http://www.statistics.gov.uk/ downloads/theme_health/hsq22_v1.pdf.
21. St. George's Hospital Medical School. Primary Care Data Quality Project. What is MIQUEST. Available at http://www.pcdq.org/MIQUEST.htm.
22. Thiru K, De Lusignan S, Sullivan F, Brew S, Cooper A. Three steps to data quality. Inform Prim Care 2003; 11: 95-102.
23. Thiru K, Hassey A, Sullivan F. Systematic review of scope and quality of electronic patient record data in primary care. Br Med J 2003; 326: 1070.
24. EMIS (Egton Medical Information Systems). Available at http://www.emis-online.com.
25. Torex (An ISoft subsidiary). Available at http://www.torex.co.uk.
26. SIGN (Scottish Inter-collegiate Guidelines Network) Publication Number 36. Antithrombotic Therapy. Available at http://www.sign.ac.uk/pdf/sign36.pdf.
27. PRODIGY (Prescribing Rationally in General Practice) PRODIGY guidance - Atrial Fibrillation. Available at http://www.prodigy.nhs.uk/guidance.asp?gt= Atrial%20fibrillation# Antithrombotic_treatment.
28. Department of Health. National Service Framework for Coronary Heart Disease (Ref: 166021P30K). London: Department of Health, 2000. Available at http://www.dh.gov.uk/PolicyAndGuidance/HealthAndSocialCareTopics/ CoronaryHeartDisease/fs/en.
29. Baker IA, Sweetnam PM, Yarnell JW, Bainton D, Elwood PC. Haemostatic and other risk factors for ischaemic heart disease and social class: evidence from the Caerphilly and Speedwell studies. Int J Epidemiol 1988; 17: 759-765.
30. Emberson JR, Whincup PH, Morris RW, Walker M. Social class differences in coronary heart disease in middle-aged British men: implications for prevention. Int J Epidemiol 2004; 33: 289-296.
31. Wheeldon NM, Tayler DI, Anagnostou, E, Cook D, Wales C, Oakley, GDG. Screening for atrial fibrillation in primary care. Heart 1998; 79: 50-55.
32. Sudlow M, Thomson R, Thwaites B, Rodgers H, Kenny RA. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community. Lancet 1998; 352: 1167-1171.
33. de Lusignan S, Singleton A, Wells S. Lessons from the implementation of a near patient anticoagulant monitoring service in primary care. Inform Prim Care 2004; 12: 27-33.
34. Hassey A, Gerrett D, Wilson A. A survey of validity and utility of electronic patient records in a general practice. Br Med J 2001; 322: 1401-1405.
35. Gray J, Majeed A, Kerry S, Rowlands G. Identifying patients with ischaemic heart disease in general practice: cross sectional study of paper and computerised medical records. Br Med J 2000; 321: 548-550.
36. Crombie DL, Cross KW, Fleming DM. The problem of diagnostic variability in general practice. J Epidemiol Commun Hlth 1992; 46: 447-454.
37. de Lusignan S, Hague N, Brown A, Majeed A. An educational intervention to improve data recording in the management of ischaemic heart disease in primary care. J Publ Hlth 2004; 26: 34-37.
38. de Lusignan S, Valentin T, Chan T, Hague NJ, Wood O, Van Vlymen J, Dhoul A. Problems with primary care data quality: Osteoporosis as an exemplar. Inform Prim Care 2004, accepted for publication.
39. de Lusignan S, Wells S, Johnson P, Meredith K, Leatham E. Compliance and effectiveness of 1 year's home telemonitoring. The report of a pilot study of patients with chronic heart failure. Eur J Heart Fail 2001; 3: 723-730.